Exploring the Neurocircuitry of the Brain and Its Impact on Treatment Selections in ADHD
Premiere Date: Wednesday, March 1, 2006This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (ANCC)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, March 1, 2007
Note: Credit Is No Longer Available
| Prakash S. Masand, MD Consulting Professor of Psychiatry Duke University Medical Center Durham, NC |
| Peter S. Jensen, MD Ruane Professor Child Psychiatry & Director Center for the Advancement of Children's Mental Health Columbia University/NY State Psychiatric Institute New York, NY |
| Stephen M. Stahl, MD, PhD Chairman, Neuroscience Education Institute Adjunct Professor of Psychiatry University of California, San Diego San Diego, CA |
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent health disorders affecting children. Children with ADHD have impaired functioning in multiple settings, including home, school, and relationships with peers. If untreated, the disorder can have long-term adverse effects into adolescence and adulthood. It is estimated that between 3 and 5 percent of children have ADHD, or approximately two million children in the United States.(1) ADHD is characterized by two core symptom areas defined as inattention and impulsivity/hyperactivity. The Diagnostic and Statistical Manual of Mental Disorders(2) (DSM-IV-TR) defines nine characteristics for inattention and impulsivity/hyperactivity, and also includes three sub-classifications of ADHD: predominantly hyperactive-impulsive (does not show significant inattention); predominantly inattentive (does not show significant hyperactive-impulsive behavior); and combined (displaying both inattentive and hyperactive-impulsive symptoms).(1) Studies have implicated a core deficit of fronto-striato-basal ganglia neurocircuitry.(3) In an effort to understand the relationship between the neurocircuitry of the brain and how neurotransmitters impact specific areas and affect cognitive functioning, this interactive, evidence-based psychCME TV activity will discuss the role of neurotransmitters in the prefrontal cortex (PFC) and their impact on brain circuitry and treatment selection in ADHD.
1. Attention Deficit Hyperactivity Disorder. http://www.nimh.nih.gov/publicat/adhd.cfm#intro Accessed 01/23/2006.
2. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 1994.
3. Dickstein DP, et al. Neurologic examination abnormalities in children with bipolar disorder or attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;58:517-524.
To provide evidence-based educational information regarding brain neurocircuitry and treatment selection in ADHD.
At the end of this CE activity, participants should be able to:
- Distinguish specific areas of the brain implicated in the pathophysiology of ADHD.
- Define the role of neurotransmission on brain circuitry in ADHD.
- Identify how brain neurocircuitry influences treatment strategies to improve patient outcomes.
- Compare and contrast existing and novel agents for the treatment of ADHD.
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals interested in mental health.
CME Credit (Physicians):
CME Outfitters, LLC, is
accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
CME Outfitters, LLC, designates this educational activity
for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with
the extent of their participation in the activity.
CNE Credit (Nurses):
This Educational Activity is
presented by CME Outfitters, LLC, which has been
approved as a provider of continuing education by
the New York State Nurses Association, an accredited
approver by the American Nurses Credentialing Center’s
Commission on Accreditation. It has been assigned code
5UYSJZ-PRV-0486. 1.0 contact hour (Pharmacology)
CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to
sponsor continuing education for psychologists. CME Outfitters maintains
responsibility for this program and its content.
(1.0 CE credits)
NASW Credit (Social Workers):
This program was
approved by the National Association of Social Workers
(provider #886407722) for 1 continuing education
contact hour.
CCMC Credit (Certified Case Managers):
This
program has been approved for 1 hour by the
Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is
accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing
pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number:
376-999-06-006-L01 (live presentation)
376-999-06-006-H01 (recorded programs)
To receive credit, participants must review all activity
materials in their entirety, score 70% or above on a post-test,
and fully complete and return both the credit request
form and activity evaluation. A certificate or statement
of credit will be mailed within 4-6 weeks to all who
successfully complete these requirements.
Disclosure Declaration
All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made on this website and within the activity course materials prior to the premiere date of this activity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-034-030106-05
